ELMELECH IDAN (COO & Principal Financial Ofcr) reported 1 transaction at BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/6/2026ACC: 0001193125-26-296503
Officer· COO & Principal Financial Ofcr
Since Apr 2026
-343.00
Net shares
Net seller
$2.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
343.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−343.00
Price / share
$7.80
Trade value
$2.68K
% of position
2.3%
7/1/2026
14.84K→14.49K
Total
Net shares
−343.00
Net value
-$2.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2026 | F · Tax Withholding | −343.00 | $7.80 | $2.68K | 2.3% | 14.84K | 14.49K |
| Total | −343.00 | -$2.68K | ||||||
Derivative Transactions0
No derivative transactions reported